Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial

Authors

Institutions

Publication Details

Journal
The Lancet Microbe
Published
2025-02-05
DOI
https://doi.org/10.1016/j.lanmic.2024.101022
Citations
4
Primary Topic
Viral Infections and Outbreaks Research
Type
article
Field-Weighted Citation Impact
5.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial

Teresa Lambe, Abigail Platt, Helen Sanders, Tanya Dinesh et al.
4 citations
The Lancet Microbe
Viral Infections and Outbreaks Research
5.58
article

Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial

Teresa Lambe, Abigail Platt, Helen Sanders, Tanya Dinesh, Eleanor Berrie, Paola Cicconi, Alison M. Lawrie, Ian Poulton, Daniel Jenkin, Rebecca Makinson, Nguyen Tran, Alex Sampson, Reece Mabbett, Jack Quaddy
article en
4 citations

Abstract

No abstract available for this paper.
The Lancet MicrobeVol. 6(5)
University of Oxford (GB), Science Oxford (GB), Jenner Institute (GB)
Innovate UK
Good health and well-being
Openalex Percentile: Top 5%
Viral Infections and Outbreaks Research
5.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.